About 40% of Americans deal with allergic conjunctivitis, according to the American Optometric Association — and most of them are overpaying or undertreating. They’re either buying the wrong OTC drops (the kind that reduce redness but don’t actually stop the allergic response) or they’re tolerating symptoms they don’t need to. The good news: effective eye allergy treatment is genuinely affordable when you know which tier of care matches your symptoms.
Here’s the cost ladder, from the cheapest option that actually works to immunotherapy for people who are done managing symptoms every year.
Tier 1 — OTC Antihistamine Drops ($15–$30/month)
The first move is ketotifen fumarate — sold as Alaway or Zaditor — a combined antihistamine and mast cell stabilizer that directly targets both the immediate histamine response and the underlying mast cell activation that drives allergic symptoms. It’s the best OTC option for most people. Dosed twice daily. A bottle lasts one to two months.
Olopatadine 0.2% (Pataday Once Daily) is now also available over the counter — once-daily dosing and strong efficacy, though it costs a bit more per bottle.
| OTC Drop | Key Ingredient | Monthly Cost | Dosing |
|---|---|---|---|
| Alaway / Zaditor | Ketotifen fumarate | $15–$30 | Twice daily |
| Pataday Once Daily (OTC) | Olopatadine 0.2% | $18–$35 | Once daily |
| Pataday Twice Daily (OTC) | Olopatadine 0.1% | $15–$25 | Twice daily |
| Generic ketotifen | Ketotifen fumarate | $10–$18 | Twice daily |
Avoid using naphazoline-based drops (original Visine, Clear Eyes) as your daily allergy treatment. These are vasoconstrictors — they shrink blood vessels to reduce redness temporarily, but with regular use they cause rebound hyperemia, where the eyes become redder when you stop using them. For actual allergy control, you need an antihistamine. Save the redness-relief drops for occasional use.
Tier 2 — Prescription Drops ($50–$150/month without insurance)
If OTC ketotifen isn’t controlling your symptoms — or if your allergy season runs long and severe — prescription drops offer stronger formulations and in some cases once-daily dosing that improves compliance.
| Prescription Drop | Drug Class | Cost Without Insurance | Generic Available? |
|---|---|---|---|
| Lastacaft (alcaftadine 0.25%) | Antihistamine | $100–$150/bottle | No |
| Bepreve (bepotastine 1.5%) | Antihistamine | $80–$130/bottle | No |
| Generic olopatadine 0.1% | Antihistamine | $20–$40/bottle | Yes — covered Tier 1 most plans |
| Cromolyn sodium 4% | Mast cell stabilizer | $15–$40/bottle | Yes |
| Loteprednol (Alrex 0.2%) | Corticosteroid | $80–$150/bottle | Limited |
Generic olopatadine is worth noting specifically: it’s the prescription version of the same molecule in OTC Pataday, usually covered at very low copays on commercial formularies, and it costs $20–$40 per bottle at retail pharmacies. Most people whose OTC drops aren’t working can get good relief with generic olopatadine for very little cost once insurance is applied.
Loteprednol and fluorometholone drops can be prescribed for moderate-to-severe flares of allergic conjunctivitis — they work well and quickly. But they’re not for daily long-term use. Prolonged steroid drop use raises intraocular pressure and can contribute to steroid-induced glaucoma and cataracts. If you’re prescribed steroid drops, your prescribing doctor should set a defined short-term course and monitor your eye pressure if the course extends beyond a few weeks. These aren’t a substitute for antihistamine drops as maintenance therapy.
Tier 3 — Allergy Testing and Immunotherapy ($200–$1,500/year)
If you’re buying eye drops every allergy season and still spending weeks with itchy, red, watering eyes — or if your symptoms run year-round — allergy testing followed by immunotherapy addresses the root cause instead of the symptoms.
The AOA notes that allergic conjunctivitis is the most common ocular allergy worldwide, and for perennial sufferers, immunotherapy is the only intervention that can reduce your underlying sensitivity rather than just blunting the response each time it fires.
Allergy testing (done by an allergist):
- Skin prick test: $200–$500 total; covered by most commercial medical plans with a referral
- Specific IgE blood panel: $150–$400; also covered with appropriate documentation
Subcutaneous immunotherapy (allergy shots):
- Build-up phase (weekly injections for 6–12 months): $800–$1,200 total
- Maintenance phase (monthly injections for 3–5 years): $400–$800/year
- Insurance: Medical plans virtually universally cover allergy shots when prescribed by an allergist following documented testing
Sublingual immunotherapy (SLIT tablets):
- FDA-approved tablets exist for grass pollen (Grastek), ragweed (Ragwitek), and dust mites (Odactra)
- Cost without insurance: $200–$400/month; often covered by commercial plans under pharmacy benefit
- Advantage: administered at home after the initial in-office dose
Punctal Plugs for Allergy-Related Dry Eye ($200–$400)
Many people with allergic conjunctivitis also develop secondary dry eye. The chronic inflammation from allergens disrupts the tear film, and frequent eye-rubbing accelerates evaporative dry eye on top of the allergic response. If you have significant dry eye symptoms alongside your allergies, your eye doctor may recommend punctal plugs — small silicone inserts placed in the tear drainage openings of the eyelids to keep more moisture on the eye surface.
Cost: $200–$400 per procedure at an eye doctor’s office, partially covered by medical insurance as a medically necessary procedure.
What Actually Works for Seasonal vs. Year-Round Symptoms
Most people with spring or fall pollen allergies do fine on OTC ketotifen during the allergy season — total cost $30–$60 per season. If your symptoms are severe enough that you’re uncomfortable through a full season, escalate to generic prescription olopatadine before jumping to costlier options.
Year-round sufferers — especially those reacting to dust mites, pet dander, or indoor molds — have a different profile. OTC drops become expensive over 12 months, and more importantly, perennial allergic conjunctivitis carries cumulative inflammation risk. For these patients, allergy testing and a conversation about immunotherapy is the financially and clinically smarter move. The AOA recommends considering immunotherapy referral when symptoms are persistent, significantly impact quality of life, or require ongoing medication that’s not adequately controlling them.
Start cheap. Escalate systematically. If you’re still miserable on OTC drops after a month, see your eye doctor — the prescription and testing tier isn’t much more expensive and works meaningfully better.
Frequently Asked Questions
Ketotifen fumarate drops (sold as Alaway or Zaditor OTC) are $15–$30 per bottle and work for most mild-to-moderate seasonal allergy sufferers. They're a dual-acting antihistamine and mast cell stabilizer, dosed twice daily, and are the starting point recommended by most eye doctors before escalating to prescription options.
OTC drops are not typically covered. Prescription drops — especially generic olopatadine — are usually covered under your medical pharmacy benefit at Tier 1 or Tier 2 copays. Vision insurance plans rarely cover medications at all. Allergy shots are covered by most commercial medical plans when prescribed by an allergist with documented testing. Always run prescription drops through medical insurance, not vision insurance.
See an eye doctor if you have eye pain, significant light sensitivity, vision changes, or thick discharge — these aren't typical allergy symptoms. Also see a doctor if OTC drops don't control your symptoms after 2–4 weeks, if you wear contact lenses and have persistent irritation, or if symptoms are year-round and interfering with daily life. Year-round symptoms often indicate perennial allergic conjunctivitis or a secondary condition like dry eye that needs targeted treatment.